| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Technical Advance |
From the Departments of Pathology,*
Biomedical Sciences
and Biotechnology,
and
Pediatrics,
University of Brescia, Brescia,
Italy; the Queen Elizabeth Hospital,§
Hong
Kong, China; the University of Verona,¶
Verona, Italy, and the Section on Lymphocyte Signaling,||
Cell Biology and Metabolism Branch, National Institutes of Health,
Bethesda, Maryland
LAT (linker for activation of T cells) is an integral membrane protein of 36–38 kd that plays an important role in T cell activation. Using a rabbit polyclonal antibody generated against the cytosolic portion of LAT, we investigated the immunohistochemical expression of LAT in normal and pathological hematolymphoid tissues. LAT reacts with human T cells in paraffin sections, including decalcified bone marrow trephines. LAT appears early in T cells at the thymocyte stage and before TdT expression in embryos, and is expressed in peripheral lymphoid tissues, without restriction to any T cell subpopulations. In addition to T cells, natural killer (NK) cells (evaluated with flow cytometry), megakaryocytes and mast cells are also LAT-positive, whereas B cells and other myeloid and monocytic derived cells are negative. Tested on a total of 264 paraffin-embedded tissue biopsies, LAT reacted with the great majority (96.8%) of T/NK-cell neoplasms, covering the full range of T cell maturation. Although antibodies to both LAT and CD3 had a similarly high sensitivity in the staining of T/NK-cell lymphomas, when used in conjunction, they successfully identified a higher number of cases (98.4%). Atypical megakaryocytes from different hematological disorders, as well as mast cells in mastocytosis were also LAT-positive, but all neoplasms of B cell origin, Hodgkin's lymphomas, and several nonlymphoid malignancies were negative. These data indicate that the anti-LAT antibody may be of value to diagnostic histopathologists for the identification of T cell neoplasms.
This article has been cited by other articles:
 |
|
 |
|
  D. Gibbings and A. D. Befus CD4 and CD8: an inside-out coreceptor model for innate immune cells J. Leukoc. Biol., August 1, 2009; 86(2): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tedoldi, J. C. Paterson, M.-L. Hansmann, Y. Natkunam, T. Rudiger, P. Angelisova, M. Q. Du, H. Roberton, G. Roncador, L. Sanchez, et al. Transmembrane adaptor molecules: a new category of lymphoid-cell markers Blood, January 1, 2006; 107(1): 213 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhu, O. Granillo, R. Wen, K. Yang, X. Dai, D. Wang, and W. Zhang Negative Regulation of Lymphocyte Activation by the Adaptor Protein LAX J. Immunol., May 1, 2005; 174(9): 5612 - 5619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhu, E. Janssen, K. Leung, and W. Zhang Molecular Cloning of a Novel Gene Encoding a Membrane-associated Adaptor Protein (LAX) in Lymphocyte Signaling J. Biol. Chem., November 22, 2002; 277(48): 46151 - 46158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Sommers, R. K. Menon, A. Grinberg, W. Zhang, L. E. Samelson, and P. E. Love Knock-in Mutation of the Distal Four Tyrosines of Linker for Activation of T Cells Blocks Murine T Cell Development J. Exp. Med., July 16, 2001; 194(2): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.E. SAMELSON, S.C. BUNNELL, R.P. TRIBLE, T. YAMAZAKI, and W. ZHANG Studies on the Adapter Molecule LAT Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 259 - 264. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
